Private company
BIORA THERAPEUTICS, INC.
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Research and development39¢$29.8M
- Selling, general and admin48¢$37.3M
- Interest13¢$9.8M
- Income tax0¢$90.0K
Out of $4.0K in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | $144.0M4 | $162.0K5 | $1.2M6 | $305.0K3 | $4.0K3 | |
| Cost of revenue | $100.5M4 | $05 | $05 | |||
| Gross profit | $43.5M4 | $162.0K5 | $1.2M5 | |||
| Research and development | $63.4M4 | $47.7M5 | $45.8M6 | $24.0M3 | $29.8M3 | |
| Selling, general and admin | $73.3M6 | $38.0M3 | $37.3M3 | |||
| Operating income | -$140.1M4 | -$107.6M5 | -$117.8M6 | -$61.8M3 | -$67.1M3 | |
| Interest | $9.2M4 | $9.9M5 | $12.6M6 | $11.0M3 | $9.8M3 | |
| Income tax | -$706.0K4 | -$37.5M5 | -$119.0K6 | -$420.0K3 | -$90.0K3 | |
| Net income | -$148.0M4 | -$192.5M5 | -$247.4M6 | -$38.2M3 | -$124.1M3 | |
| Earnings per share | -$64.336 | -$5.003 | -$7.873 | |||
| Earnings per share (diluted) | -$64.336 | -$5.003 | -$7.873 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash | $33.0M4 | $92.1M5 | $88.4M6 | $30.5M6 | $15.0M3 | |
| Current assets | $74.6M4 | $126.3M5 | $98.8M6 | $38.1M3 | $19.1M3 | |
| Total assets | $101.7M4 | $154.4M5 | $108.8M6 | $53.5M3 | $31.2M3 | |
| Current liabilities | $100.3M4 | $72.7M5 | $61.6M6 | $23.3M3 | $63.0M3 | |
| Total liabilities | $185.6M4 | $261.4M5 | $193.8M6 | $155.8M3 | $132.6M3 | |
| Shareholders’ equity | -$37.0M4 | -$83.9M5 | -$107.0M6 | -$85.0M3 | -$102.3M3 | -$101.4M3 |
| Shares outstanding | 5.0M shares4 | 55.8M shares5 | 184.1M shares5 | 8.9M shares3 | 27.8M shares3 |
Former names
Recent filings
- Dec 30, 20248-K CURRENT REPORT
- Dec 16, 20244
- Dec 10, 20248-K
- Nov 15, 20248-K
- Nov 14, 20248-K
- Nov 14, 202410-Q
- Oct 29, 20248-K
- Oct 23, 2024DEF 14A
- Oct 11, 20248-K
- Oct 7, 20248-K
- Sep 16, 2024DEF 14A
- Sep 13, 20248-K
- Sep 5, 20248-K
- Aug 21, 20248-K
- Aug 16, 20244
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8